Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 2,014 |
| Gross Profit | N/A | N/A | N/A | N/A | 2,014 |
| Operating Expenses | 17,878 | 18,559 | 38,829 | 14,221 | 11,600 |
| Operating Income | -17,878 | -18,559 | -38,829 | -14,221 | -9,586 |
| Interest Expense | 0 | 0 | 2 | 4 | 8 |
| Other Income | 374 | 575 | -6 | 40 | -54 |
| Pre-tax Income | -17,504 | -17,984 | -38,837 | -14,185 | -9,648 |
| Net Income Continuous | -17,504 | -17,984 | -38,837 | -14,185 | -9,648 |
| Net Income | $-17,504 | $-17,984 | $-38,837 | $-14,185 | $-9,648 |
| EPS Basic Total Ops | -1.72 | -1.87 | -4.77 | -0.16 | -2.04 |
| EPS Basic Continuous Ops | -1.72 | -1.86 | -4.77 | -1.93 | -2.10 |
| EPS Diluted Total Ops | -1.72 | -1.87 | -4.77 | -0.16 | -2.04 |
| EPS Diluted Continuous Ops | -1.72 | -1.86 | -4.77 | -1.93 | -2.10 |
| EPS Diluted Before Non-Recurring Items | -1.72 | -1.87 | -2.23 | -1.92 | -2.04 |
| EBITDA(a) | $-17,432 | $-19,947 | $-19,349 | $-13,839 | $-9,250 |